Literature DB >> 33966888

A North American prospective study of depression, psychotropic medication use, and semen quality.

Jennifer J Yland1, Michael L Eisenberg2, Elizabeth E Hatch3, Kenneth J Rothman4, Craig J McKinnon3, Yael I Nillni5, Greg J Sommer6, Tanran R Wang3, Lauren A Wise3.   

Abstract

OBJECTIVE: To evaluate the associations of a history of diagnosed depression, current depressive symptoms, and recent use of psychotropic medications with semen quality and to consider mediation of the association between depression and semen quality by medication use.
DESIGN: Prospective cohort study.
SETTING: United States. PATIENT(S): The patients were 329 men aged ≥21 years (566 semen samples) who participated in a semen-testing substudy of Pregnancy Study Online. Pregnancy Study Online is an ongoing, web-based preconception cohort study of couples attempting to conceive. At baseline, participants reported information about depression diagnosis, depressive symptoms using the Major Depression Inventory, medication use in the last 4 weeks, and selected covariates. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The men used an at-home semen-testing kit (Trak; Sandstone Diagnostics, Inc., Pleasanton, California) to measure semen volume, sperm concentration, and motile sperm concentration. We calculated percent motility, total sperm count in the ejaculate, and total motile sperm count. RESULT(S): Forty-nine men (15%) reported a history of depression diagnosis, and 41 (12%) reported recent use of psychotropic medications. A history of depression diagnosis was associated with a 4.3-fold increase in the risk of low semen volume (<1.5 mL) (95% CI 1.16, 16). A 5-unit increase in Major Depression Inventory score was associated with a 1.38-fold increase in the risk of low semen volume (95% CI 0.92, 2.1). The results for other semen parameters were inconsistent. Recent use of psychotropic medications was associated with worse semen quality, and this association was confounded by a history of depression diagnosis. The observed association between depression and semen volume showed little mediation by psychotropic medication use.
CONCLUSION: A history of diagnosed depression and severe depressive symptoms at enrollment were associated with low semen volume.
Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; psychotropic medications; semen analysis

Mesh:

Substances:

Year:  2021        PMID: 33966888      PMCID: PMC8410630          DOI: 10.1016/j.fertnstert.2021.03.052

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.490


  41 in total

1.  Sperm morphology, motility, and concentration in fertile and infertile men.

Authors:  D S Guzick; J W Overstreet; P Factor-Litvak; C K Brazil; S T Nakajima; C Coutifaris; S A Carson; P Cisneros; M P Steinkampf; J A Hill; D Xu; D L Vogel
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Correlation between premature ejaculation and psychological disorders in 270 Chinese outpatients.

Authors:  Tao Liu; Chao Jia; Yi-Feng Peng; Wan Zhong; Xiang Fang
Journal:  Psychiatry Res       Date:  2018-12-06       Impact factor: 3.222

Review 3.  Epidemiology and aetiology of male infertility.

Authors:  D S Irvine
Journal:  Hum Reprod       Date:  1998-04       Impact factor: 6.918

4.  Novel centrifugal technology for measuring sperm concentration in the home.

Authors:  Ulrich Y Schaff; Laura L Fredriksen; Jon G Epperson; Tiffany R Quebral; Sara Naab; Mark J Sarno; Michael L Eisenberg; Greg J Sommer
Journal:  Fertil Steril       Date:  2016-11-22       Impact factor: 7.329

5.  Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings.

Authors:  Robert A Power; Simon Kyaga; Rudolf Uher; James H MacCabe; Niklas Långström; Mikael Landen; Peter McGuffin; Cathryn M Lewis; Paul Lichtenstein; Anna C Svensson
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

6.  Antidepressant use: concordance between self-report and claims records.

Authors:  Anne Kwon; Kathleen M Bungay; Yu Pei; William H Rogers; Ira B Wilson; Qi Zhou; David A Adler
Journal:  Med Care       Date:  2003-03       Impact factor: 2.983

7.  Abstinence Time and Its Impact on Basic and Advanced Semen Parameters.

Authors:  Ashok Agarwal; Sajal Gupta; Stefan Du Plessis; Rakesh Sharma; Sandro C Esteves; Caroline Cirenza; Jasmine Eliwa; Wedad Al-Najjar; Deepika Kumaresan; Namariq Haroun; Sara Philby; Edmund Sabanegh
Journal:  Urology       Date:  2016-05-16       Impact factor: 2.649

Review 8.  World Health Organization reference values for human semen characteristics.

Authors:  Trevor G Cooper; Elizabeth Noonan; Sigrid von Eckardstein; Jacques Auger; H W Gordon Baker; Hermann M Behre; Trine B Haugen; Thinus Kruger; Christina Wang; Michael T Mbizvo; Kirsten M Vogelsong
Journal:  Hum Reprod Update       Date:  2009-11-24       Impact factor: 15.610

9.  Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros.

Authors:  Linda Valeri; Tyler J Vanderweele
Journal:  Psychol Methods       Date:  2013-02-04

Review 10.  Sexual dysfunction related to psychotropic drugs: a critical review--part I: antidepressants.

Authors:  A La Torre; G Giupponi; D Duffy; A Conca
Journal:  Pharmacopsychiatry       Date:  2013-06-04       Impact factor: 5.788

View more
  2 in total

1.  A Prospective Study of Male Depression, Psychotropic Medication Use, and Fecundability.

Authors:  Jennifer J Yland; Craig J McKinnon; Elizabeth E Hatch; Michael L Eisenberg; Yael I Nillni; Kenneth J Rothman; Lauren A Wise
Journal:  Am J Mens Health       Date:  2022 Jan-Feb

2.  The effect of SSRIs on Semen quality: A systematic review and meta-analysis.

Authors:  Jiarong Xu; Kancheng He; Yihong Zhou; Liangyu Zhao; Yuteng Lin; Zihao Huang; Nengqing Xie; Jihui Yue; Yuxin Tang
Journal:  Front Pharmacol       Date:  2022-09-14       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.